Pacer Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-28,277
Closed -$1.96M 3515
2025
Q1
$1.96M Buy
28,277
+1,387
+5% +$96.3K ﹤0.01% 959
2024
Q4
$2.31M Buy
26,890
+44
+0.2% +$3.79K 0.01% 898
2024
Q3
$3.2M Sell
26,846
-1,295
-5% -$154K 0.01% 772
2024
Q2
$4.02M Sell
28,141
-885
-3% -$126K 0.01% 643
2024
Q1
$3.73M Sell
29,026
-680
-2% -$87.3K 0.01% 664
2023
Q4
$3.07M Buy
29,706
+14,702
+98% +$1.52M 0.01% 680
2023
Q3
$1.36M Sell
15,004
-12,060
-45% -$1.1M 0.01% 716
2023
Q2
$2.19M Buy
27,064
+1,636
+6% +$132K 0.01% 703
2023
Q1
$2.02M Buy
25,428
+816
+3% +$64.9K 0.01% 718
2022
Q4
$1.67M Buy
+24,612
New +$1.67M 0.01% 607
2022
Q1
Sell
-25,352
Closed -$1.42M 2471
2021
Q4
$1.42M Sell
25,352
-798
-3% -$44.7K 0.01% 1001
2021
Q3
$1.26M Buy
26,150
+816
+3% +$39.2K 0.02% 785
2021
Q2
$1.06M Sell
25,334
-200
-0.8% -$8.38K 0.02% 822
2021
Q1
$861K Sell
25,534
-1,370
-5% -$46.2K 0.02% 838
2020
Q4
$940K Sell
26,904
-6,028
-18% -$211K 0.02% 728
2020
Q3
$1.14M Buy
+32,932
New +$1.14M 0.02% 646
2020
Q1
Sell
-25,200
Closed -$729K 967
2019
Q4
$729K Buy
25,200
+7,020
+39% +$203K 0.03% 653
2019
Q3
$470K Buy
18,180
+5,740
+46% +$148K 0.01% 1005
2019
Q2
$317K Buy
+12,440
New +$317K 0.01% 1022
2017
Q4
Sell
-2,324
Closed -$56K 1256
2017
Q3
$56K Buy
+2,324
New +$56K 0.01% 1100
2013
Q4
$311K Buy
+73,500
New +$311K 0.07% 352